For instance, the results of a recent study have indicated that OCT1 involved in sorafenib transport is downregulated in DEN-induced HCC, which correlated with impaired sorafenib uptake by cancer cells [107]. This evidence concerns the gene SLC22A1 and hepatocellular carcinoma.